The FDA-approved drug combination specifically targets low-grade serous ovarian cancer, which primarily affects younger women ...

Cancer is a disease that starts with uncontrolled cell division and eventually causes tissue and organ damage. The disease ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

The discovery could pave the way for new treatments, improved risk prediction, and earlier intervention for brain metastases.

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

A new study has found that high uptake of school-based immunisation against human papillomavirus (HPV) could also offer ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

Newly Hong Kong-listed biotech firm Insilico Medicine is expected to receive up to US$888 million from a French drug maker ...

The at-home tests are not yet available, but the U.S. Food and Drug Administration approved two self-swab tests from the ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...